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1.2 Summary 
Globally the incidence of macrosomic newborns is increasing. In Norway the percentage of 
newborns weighing 4,000g or more has increased from 16 to 20% in less than three decades. 
Newborn macrosomia is associated with short-and long-term health risks for the infant, and 
increases the prevalence of birth complications. Parity, maternal age and gender of the child 
influence fetal growth. Maternal overweight is a risk factor for gestational diabetes (GDM) 
and newborn macrosomia. Some women with high body mass index (BMI) give birth to 
macrosomic newborns while others do not. Maternal lifestyle factors are potential predictors 
of pregnancy complications. Boys are heavier at birth than girls, but girls have higher fat mass 
at birth than boys.  
During the period of 2002 and 2005 the STORK-study followed a total of 553 pregnant 
women through pregnancy and childbirth at the Department of Obstetrics and Gynecology, 
Rikshospitalet. 
The aims of this thesis were to evaluate the contribution of modifiable factors that may 
influence the risk of fetal macrosomia. The first aim was to explore the roles of physical 
inactivity, BMI and fasting plasma glucose. A second aim was to study the impact of physical 
inactivity on delivery complications. The third aim was to examine whether maternal fasting 
plasma glucose levels influence birth weight in the two sexes differently.  
Pregestational physical inactivity, glucose and high BMI were independent determinants of 
fetal macrosomia. Pregestational physical inactivity increased the risk of perineal laceration 
degree three to four. Overweight women with an increase in fasting plasma glucose from 
early to late pregnancy had a 4.5-fold increase in risk of newborn macrosomia compared to 
the remaining group with a high BMI. The effect of maternal fasting plasma glucose on birth 
weight in girls was twice as high as in boys. Paternal birth weight was significantly associated 
with birthweight of boys, but no such association was seen for girls 
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1.3 Abbreviations 
NCD   Non-communicable diseases  
PE   Preeclampsia  
GDM   Gestational diabetes  
NGT  Normal glucose test  
IGT  Impaired glucose tolerance 
BMI   Body mass index (weight (kg)/height (cm2) 
HDL   High density lipoprotein  
FPG   Fasting plasma glucose  
CVD   Cardiovascular disease  
LGA  Large for gestational age  
SGA   Small for gestational age  
AGA   Average for gestational age  
EDA   Epidural analgesia 
DXA   Dual energy X-ray absorptiometri  
FM   Total fat mass  
FFM   Fat-free mass  
CS   Cesarean Section  
MET  metabolic equivalent task (1 MET=3.5 mL O2 uptake /kg body weight x 1 min 
or 1 kcal /kg body weight x h) 
PAPQ   Physical Activity and Pregnancy Questionnaire  
HOMA-IR  Insulin resistance ((FPG * FPI) / 22.5) 
OGTT  Oral glucose tolerance test  
T2DM  Type 2 diabetes mellitus  
ACOG  The American College of Obstetricians and Gynecologists  
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IOM   Institute of Medicine  
EGIR   European Group for the Study of Insulin Resistance  
IDF   International Diabetes Federation  
DOHaD  Developmental Origins of Health and Disease  
FOAD  Fetal Origins of Adult Disease   
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 2 Introduction 
The prevalence of macrosomic newborns frequently defined as birth weight above 4000g or 
4500g has increased both in Norway and world-wide the last 20 – 30 years. The Norwegian 
Medical Birth Registry has since 1967 registered all births in Norway and the prevalence of 
newborns with birth weight above 4000g has increased from about 16% in 1967 to 19% in 
2008. Children weighing 4500g or more have increased from 3% to 4.5% in the same time 
interval (1). The prevalence of macrosomia is increasing also in other Scandinavian countries 
(2;3). By identifying some of the modifiable determinants it may be possible to reduce the 
numbers of infants born with high birth weight.  
The increasing prevalence of overweight and obesity is becoming a world wide problem, in 
both developed and developing countries. The problem appears to increase most in the 
younger age groups (4). Between mid 1980 and mid 1990 the prevalence of obesity in 
Norway increased from 11 – 21% among women (5). The increase was highest in the 
youngest age groups. A consistency between low level of physical activity, overweight and 
high mean diastolic blood pressure has been shown (6).  
Obesity may be seen as one of the key risk factors for non-communicable diseases (NCD), 
which accounts for about 60% of all deaths worldwide (7). In the USA smoking still remains 
the leading cause of mortality. However, poor diet and physical inactivity may soon overtake 
tobacco as the leading cause of death (8). In the UK, obesity is now the most common clinical 
risk factor encountered in obstetric practice (9). In a report from Confidential Enquiries into 
Maternal and Child Health obesity was identified as a risk factor for maternal death, finding 
that 35% of all mothers who died were obese, which represents a disproportionate number of 
deaths associated with obesity in childbearing women (10). Chronic diseases associated with 
obesity are cardiovascular diseases and hypertension, cancer, diabetes mellitus and 
gallbladder disease. What has recently been shown is that adipocytes are more than just fat 
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depots. They function as endocrine cells, producing hormones and as target cells for many 
hormones. Insulin resistance is often associated with obesity, and is especially pronounced 
with intra-abdominal fat accumulation (11). 
 
 
3 Obesity  
3.1 Obesity & pregnancy 
As obesity alone represents increased disease risk, obesity in pregnancy presents added health 
problems (12). Several publications show significant associations between maternal obesity 
and complications during pregnancy and delivery (13;14). Pregnancy complications include at 
the most severe increased risk for intrauterine death (15), and nulliparous have increased risk 
for extreme premature delivery (16). It is also shown that risk of fetal growth restriction 
unrelated to preeclampsia was found in obese nulliparous women (12). This contrasts the 
finding that obesity protected against fetal growth restriction (17). Maternal obesity has been 
found to increase the risk for macrosomia (15), the risk for acute caesarean section, prolonged 
labor, and severe haemorrhage (18;19). Obese and overweight women have higher risks for 
developing complications such as preeclampsia (PE) and gestational diabetes (GDM) (19). It 
has been shown that fat-free mass in infants of the mothers with GDM was significantly less 
compared with the infants of the normal glucose test group (NGT) (13). Birth weight alone 
may not be a sensitive enough measure to recognize differences in fetal growth in certain 
populations. Insulin sensitivity in early pregnancy may therefore be related to maternal 
metabolic changes affecting fetoplacental growth and metabolism in the utero environment 
(13). 
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3.2 Weight gain before pregnancy and weight retention after delivery 
Excessive weight gain in pregnancy and interpregnancy weight gain increase the risk for 
adverse outcome in the next pregnancy (20). Pregravid body mass index (BMI, weight 
(kg)/height 2 (m)) is often associated with macrosomic newborns and complications during 
pregnancy and delivery (16). It  has been shown that weight gain between pregnancies 
increases the risk of adverse pregnancy outcome in the next pregnancy also in women who 
were not overweight, including increased risk for large for gestational age (LGA) (20). 
Increase in BMI from normal to obese between the first and second pregnancies showed 
enhanced risk for delivering a LGA infant, whereas a decrease in pregravid BMI from obese 
to normal in the second pregnancy attenuated the elevated risk for a LGA birth (21). 
 
3.3 Weight gain during pregnancy 
Both epidemiological studies and animal models have shown that there are strong associations 
between low birth weight and subsequent risk of developing metabolic syndrome, insulin 
resistance, obesity or coronary heart diseases in later life (22). In the Western societies the 
opposite problem may be more likely to occur, that is, newborn infants being borne too large. 
In the UK there has been a two-fold increase in women being recognized as obese at booking 
visits, and nearly one in five women booking for antenatal care in 2002/2004 at Glasgow 
Maternity Hospital was obese (15;23). 
Recommended weight gain during pregnancy above guidelines is associated with high birth 
weight, macrosomia or LGA-infant (24), hypoglycemia or hyperbilirubinemia in the 
newborns (25). There is not yet a general agreement on the recommended weight gain for 
women in the different prepregnancy BMI classes (26). In 1990 the Institute of Medicine 
(IOM) reported in Nutrition During Pregnancy how much women should gain during 
pregnancy (27). The main focus was then on children born too small; now the focus has 
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shifted to those who gain too much. The recommendation was divided into BMI-groups 
(Table 1). Several studies confirm that a substantial proportion of normal-weight women and 
an even greater proportion of overweight women gain more than is recommended (28). 
Evaluating gestational weight gain in a normal weight group of pregnant women found that 
adherence to the current IOM guidelines results in lower risks for adverse pregnancy, labor 
and delivery outcomes when comparing all outcomes collectively. However, only 40% gained 
the recommended amount of weight during pregnancy, whereas 18% and 43% gained less or 
more than recommended (29). Gestational weight gain and pregnancy outcomes in obese 
women need to be divided into obesity classes; grade I (BMI 30 – 35), grade II (BMI 35 – 
40), and grade III (BMI > 40). Minimal risk may correspond to a weight gain of 10 – 25 lb 
(4.5 - 11.3kg) for class I obese women, a weight gain of 0 – 9 lb (0 – 4.1kg) for class II obese 
women and a weigh loss of 0 – 9 lb (0 – 4.1kg) for class III obese women (26). The 
prevalence of pre eclampsia, LGA and caesarean delivery increase with increased BMI-
classes, while the prevalence of SGA-children is reduced (30). Weight gain limits for BMI 
categories has decreased the risk for adverse obstetric and neonatal outcome has been 
associated with lower gestational weight gain than was earlier recommended, especially 
among obese women (26).  
 
Table 1 Recommended total weight gain ranges for pregnant women by pre-pregnancy BMI (9;26) 
pre-pregnancy BMI         Recommended  
weight gain (kg) [Cedergren(26)] 
Recommended  
weight gain (kg) [IOM (27)] 
Underweight, < 19.8 [< 20] 4 - 10 12.5 – 18 
Normal, 19.8 – 24.9 [20-24.9] 2 - 10 11.5 – 16 
Overweight, 25 – 29.9 [25-29.9] Less than 9 7 – 11.5 
Obese, > 29.9 [ 30] Less than 6 At least 6.8 
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4 The metabolic syndrome  
The syndrome as we recognize it today was first described as “Syndrome X” by Reaven in 
1988, and it was established as clinical important, although obesity was not included (31). 
This syndrome is now accepted as a cluster of metabolically related symptoms which predict a 
high risk of developing cardiovascular risk as well as diabetes (if not already present). There 
are several definitions to this syndrome worldwide made by the World Health Organization 
(WHO) (1999), the European Group for the Study of Insulin Resistance (EGIR) (1999), and 
National Cholesterol Education Program – Third Adult Treatment Panel (NCEP ATP III) 
(2001).The last attempt to make a world-wide definition has come from International Diabetes 
Federation (IDF) from a workshop in 2006 (32). Their definition is ethnic specific, and says 
that the syndrome contains of central obesity, raised triglycerides and reduced high density 
lipoprotein (HDL), cholesterol, raised blood pressure and raised fasting plasma glucose (FPG) 
(32). As pregnancy in itself is a metabolically state with features of metabolic syndrome these 
definitions cannot be relocated to pregnant women (33-35). An increasing number of women 
will have established a metabolic syndrome as they enter into pregnancy. The increased 
physiological demands that occur during pregnancy often unmask subclinical conditions that 
disappear after pregnancy but that may emerge later in women’s life. Pregnancy has therefore 
been considered as a “stress-test” for metabolic and cardiovascular conditions (36).  
There are two differentiated metabolic stages during pregnancy. The first stage corresponds to 
the first two thirds of pregnancy, when fetal growth is limited. During this period the maternal 
metabolism is anabolic and directed towards storing accumulated nutrients. The last third 
period of pregnancy is a period of rapid fetal growth, and growth is supported by a maternal 
switch to catabolic metabolism and enhanced transfer of nutrients by the placenta. This 
metabolic balance is ideal to provide a continuous supply of nutrients of fetal and placental 
growth. In a population of women with impaired glucose tolerance (IGT) or GDM it was 
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found that obesity rather than glucose correlated best with fetal macrosomia (37). Only FPG 
levels at week 32-35 weeks of gestation correlated with fetal macrosomia. It is also speculated 
that obesity and metabolism are closer associated with macrosomia than hyperglycemia (38).  
 
 
5 Gestational diabetes and glucose intolerance 
GDM is described as carbohydrate intolerance of varying degrees of severity with onset or 
first recognition during pregnancy (39). The primarily reason to identify GDM was to detect 
women of risk to develop type 2 diabetes mellitus (T2DM) later in life. The focus has now 
shifted to identify women with GDM to detect pregnancies at risk for potential adverse 
outcome as a result of maternal hyperglycemia (40). In recent years it has been a global 
increase in the prevalence of obesity and T2DM, as well as an increasing prevalence of GDM 
(41). This may be due to increased maternal age, the epidemic of obesity and diabetes, 
decrease in physical activity and the adoption of modern lifestyles in developing countries 
(42). Considerable controversy exists regarding the thresholds and the numbers of the plasma 
glucose values considered for diagnosis of GDM during oral glucose tolerance testing (43). 
There still remains a need to develop diagnostic criteria for GDM that are based on the 
relationships between hyperglycemia and risk of adverse outcome (44). Pregnancy is 
characterized by an increased insulin secretion to compensate the increased requirements. In 
GDM the pancreatic ß-cell function is characterized by insufficiency to meet the body’s 
insulin needs (45). Thus, robust plasticity of ß-cell function in the face of progressive insulin 
resistance prevail normal glucose regulation during pregnancy (46). 
Women developing GDM is at high risk of developing type 2 diabetes mellitus (T2DM) later 
in life. As the registered prevalence of GDM in the United States varies from 3 – 12 %, it is 
inaccurate to predict who will develop T2DM (47). In Norway the registered prevalence of 
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GDM in 2006, was 10.6 per 1000. The lowest registered number was in the county of 
Telemark (3/1000), whereas the highest was in the neighbor county of Buskerud (19.4/1000) 
(1). In the same way as the metabolic syndrome, GDM can be seen as a stress test for the 
development of T2DM. There are indications that as many as 50% of women who develop 
GDM subsequently will develop T2DM (47). Women with previous GDM have a prevalence 
of cardiovascular disease (CVD) due to the cluster of establishing the metabolic syndrome 
(48). Many women have one or more additional pregnancies after the diagnosis of GDM, and 
a high proportion (> 50%) of these are reported to have GDM in the subsequent pregnancy 
(49). 
Figure 1 
 
 Diabetes begets diabetes: the alterations of maternal fuel metabolism lead to altered fetal islet function 
(hyperinsulinism). This intrauterine event predisposes to, or identifies risk for childhood obesity and adolescent 
IGT, GDM, and later DM. Reproduced from Diabetes in Women. 3rd ed. Philadelphia, PA: Lippincott Williams 
& Wilkins; 2004 with permission (50)
 
In 1954 it was postulated that maternal hyperglycemia leads to high insulin and glucose in the 
fetus, the “Pedersen hypothesis” (51;52). Glucose is known to pass the placenta barrier, 
whereas insulin does not. Intrauterine exposure to maternal diabetes is associated with excess 
fetal growth in utero, possibly due to an increase in fetal fat mass and alterations in fetal 
hormones (53). Concentrations of insulin are raised, and it has also been shown that increase 
in fetal leptin is associated (54).   
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Historically, stillbirth was an important complication of diabetic pregnancies, whereas the 
most frequent types of morbidity now are associations with macrosomia and labor 
complications (55). Intrauterine exposure to an excess of glucose, may lead to permanent fetal 
changes, such as malformations, macrosomia, increased risk for obesity and developing 
T2DM in later life. Studies of the Pima Indians have shown that exposure to hyperglycemia in 
fetal life, are at increased risk of becoming obese and developing diabetes at young ages (54). 
The HAPO-study is a multicenter study with a total of 25 000 pregnant women at 15 different 
centers in nine countries. The results indicate strong and continuous associations between 
maternal blood glucose values, also below those diagnosed for GDM, with increased birth 
weight, primary cesarean delivery and cord-blood serum C-peptide levels. This study 
indicates the need to re-consider the criteria for diagnosing and treating hyperglycemia during 
pregnancy (56). 
 
 
6 The role of intrauterine environment, Developmental Origins of Health 
and Disease (DOHaD) 
David Barker proposed in the late nineteen eighties that newborns born small for gestational 
age performed higher risks of developing CVD, diabetes or obesity at an earlier age than 
newborns within a normal weight range (57). This work was, among others, based upon that 
of Forsdahl who in the late 1970s described that children with Finnish origin who grew up in 
Finmark (north of Norway) and were exposed to poor living conditions in childhood and 
adolescence experienced a higher mortality rate of coronary heart diseases when adult (58). 
As mentioned above, chronic NCD which include cardiovascular conditions, some cancers, 
and chronic respiratory conditions and T2DM are reaching epidemic proportions and account 
for 44% of premature deaths world wide. Commonly known risk factors include lack of 
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exercise and improper diet and smoking. Though these are diseases that are preventable, most 
countries have focused more on biomedical research and treatment rather than prevention (7). 
There is a growing body of evidence that intrauterine conditions may have a significant 
impact on future health and disease is becoming well acknowledged (57;59-65). “Intrauterine 
programming” is a process by which early insults at critical stages of development lead to 
permanent changes in tissue structure and function (66). This is now called the DOHaD 
concept, developing from the FOAD concept (Fetal Origins of Adult Disease). Studies 
suggest that early environmental factors may change development without affecting birth 
weight, and the most widely accepted phenomenon is that of programming. This is described 
as a process whereby a stimulus or insult has irreversibly long-term effects on development 
(67). There may be three different pathways of relevance. One is the so-called “mismatch” 
pathway, which reflects the studies by Barker and his group, describing newborns with 
impaired fetal growth and postnatal excessive weight gain. Another potential pathway are 
newborns with rapid weight gain, often due to formula feeding, whilst the third pathway 
reflects the macrosomic infants often born to diabetic or obese women, and who later become 
insulin resistant or obese (68). 
 
 
7 Determinants of fetal growth 
7.1 Pregnancy, nutrition and birth weight 
The placenta plays an important role as a new endocrine organ established only a few weeks 
of conception, secreting hormones that affect the nutrients metabolism. The adjustments are 
driven by hormonal changes, fetal demands and maternal nutrient supply, and each nutrient 
has more than one potential adjustment (69). There are thorough distinctions between 
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maternal nutrition and fetal nutrition. The fetus grows at the end of a long “supply line”, 
starting with maternal diet at one end and fetal tissue uptake at the other (70). 
 
Figure 2 
 
The fetal supply line. Factors along the fetal ‘supply line’ which can mediate the differences between maternal 
nutrition and fetal nutrition. (71) 
 
The placenta plays an important role in the fetal supply line and influences fetal nutrition via 
its own metabolic demand for nutrients. Lactogen and growth hormone that are produced by 
placenta contribute to maternal insulin resistance. The availability of glucose and other 
nutrients in the maternal circulation may increase the transfer to the fetus (71). 
Most studies of the relationship between maternal nutritional status during pregnancy and 
glucose tolerance in offspring have looked at the effect of reduced maternal nutrition during 
pregnancy. Only a few studies have investigated the periconceptual nutritional status and long 
term health status. In sheep models it has been found that maternal periconceptual 
undernutrition impairs glucose tolerance in postpubertal offspring. Maternal nutrition around 
the time of conception may therefore have important implications for glycaemic regulation in 
the next generation (72). 
The Dutch famine that occurred near the end of World War II is the most well known study 
on humans in relation to under nutrition during pregnancy. The association to adult health of 
infants born by pregnant women exposed to famine was related to the stage of pregnancy 
when exposed. Exposure of starvation during any stage of gestation was associated with 
impaired glucose tolerance (73), exposure to famine during early gestation was related to 
obesity in women (74) and a greater prevalence of coronary heart disease (75). Exposure of 
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famine during the last trimester of pregnancy reduced birth weigh by around 10% (75). Early, 
mid- or periconceptual exposure did not affect birth weight in one study (76), but mid-
pregnancy exposure mildly reduced birth weight, and early gestation exposure slightly 
increased birth weight in another study (75). Several epidemiological studies are related to 
fetal nutritional deprivation as a strong programming stimulus. In many societies, however, 
maternal and postnatal nutrition are either sufficient or excessive. Obesity and excessive 
weight gain may therefore be the more common nutritional problems related to pregnancy 
complications in developed countries. Not many studies have investigated long-term 
consequences of maternal nutrient excess during pregnancy or lactation on development of 
obesity in offspring (77). 
Growing evidence has pointed out that overweight or obesity and excessive weight gain 
during pregnancy is important maternal factors that increase the risk for macrosomia. The 
direct link between nutritional associations and birth weight is not obvious. It has been found 
that a maternal dietary pattern in pregnancy based on red and processed meat and high-fat 
diary, was associated with increased risk for small for gestational age (SGA) (78) whereas 
others have found that nutritional intake during pregnancy is not reflected with birth size 
variables (79). Other studies as well report negative associations between energy, 
carbohydrate and fat consumption in early pregnancy and size of newborn or placenta at birth 
(80;81). In Australia it was found that dietary composition of women in early, but not in late, 
pregnancy was associated with an increased size of infant at birth (82). 
The influence of micronutrients on birth weight during pregnancy is less investigated. One 
human study investigating 20 different vitamins and micronutrients, found that only vitamin E 
was associated with birth weight (83). However, a study of Wistar rats during pregnancy 
found that high vitamin intake during pregnancy increases the phenotypic expression of 
obesity and components of the metabolic syndrome in both female and male rats fed an 
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obesogenic diet (84). Micronutrient metabolism and absorption can be influenced by dietary 
nutrient balance, and by factors such as infection, genetics and smoking (85). 
Most information on pregnancy dietary composition is mainly based on studies in mid- to late 
pregnancy. However, the importance of periconceptual intake of nutrients, such as folate acid 
is established (85). Maternal weight at conception probably influences metabolic adaptation to 
pregnancy and may also indicate the importance of prepregnancy nutrition (69). 
7.2 Physical activity and exercise, pregnancy and birth weight 
Prior to the 1980s, the guidelines restricted pregnant women from strenuous exercise, 
believing that this would deprive the fetus of oxygenated blood flow and metabolic fuels 
causing fetal distress and growth restriction(86). Primary recommendations to promote and 
maintain health in healthy adults is moderate-intensity aerobic physical activity for a 
minimum on 30 min on five days each week or vigorous-intensity aerobic physical activity for 
a minimum of  20 min on three days each week (87). The American College of Obstetricians 
and Gynecologists (ACOG) now supports the guidelines that in the absence of either medical 
or obstetric complications, pregnant women also can adopt this recommendation (88). 
However, the optimal dose of recreational physical activity for a pregnant women remains to 
be determined, and the impact of prolonged and repeated aerobic exercise on outcome of 
clinical importance for mothers and infants is unknown (89;90). Some observational studies 
have associated physically demanding work with increased risk of preterm birth (91;92). It 
has also been reported increased risk of early miscarriage in pregnancies associated with high 
impact exercise (more than seven hours/week) (93). 
However, a growing body of evidence supports the idea that physical activity is beneficial in 
preventing or treating maternal-fetal diseases. The health risk associated with continuation or 
adoption of a sedentary lifestyle during pregnancy may contribute to conditions such as 
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childhood obesity, GDM, preeclampsia, deep vein thrombosis and poor psychological 
adjustment to the physical changes of pregnancy (86). Many studies are related to glucose 
values and the risk of GDM, and evidence shows that regular physical activity before 
pregnancy is associated with lower GDM risk (94;95). As GDM is a risk factor for 
macrosomia, reducing GDM will reduce the risk of delivering macrosomic infants as well. 
Physical activity among GDM’s reduces the prevalence of obesity, which is known to be 
strongly associated with macrosomia (96-98). The long-term effects of continuing exercise 
during pregnancy has recently been evaluated. By following women 18–20 years after 
pregnancy it was shown that women who continue vigorous recreational exercise after their 
index pregnancy maintain their long-term fitness and have a low cardiovascular risk profile in 
the perimenopausal period (99). Most studies on physical exercise and birth outcomes are 
small and they measure different outcomes. It is not always specified whether they measure 
physical activity (defined as any bodily movement produced by skeletal muscles resulting in 
energy expenditure), exercise and/or training (repetitive bouts of exercise with the intension 
of developing physical fitness) or moderate exercise (corresponding to brisk walking) 
(100;101). Also, there are methodological aspects as how to best assess information of 
physical activity among women during pregnancy.  
One of the main concerns about physical exercise during pregnancy has been the fear of 
growth restriction due to competition with maternal environment for excess to main energy 
resource or that physical activity reduces insulin secretion and may cause reduction of fetal 
growth (86).  
The reasons for discrepancy in studies concerning prenatal physical activity and birth weight 
are complex. The estimates of total activity load may be inaccurate. The effects vary with 
differences in type, intensity, duration and frequency and the exercise effects can be modified 
by maternal diet (102). It has also been shown that reduced birth weight delivered by 
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exercising mothers, was due to reduction of fetal fat mass, or contrary, that that reduced fat 
mass in the newborn was associated with brisk walking during pregnancy by the mother 
(103;104). 
Validated questionnaires in prospective studies measured at different time points during 
pregnancy that measures the type, frequency and duration of physical activity or 
accelerometers worn by the pregnant women is the most reliable tool to assess physical 
activity during pregnancy (90). Also, asking women to recall pregnancy recreational physical 
activity after delivery has major limitations because delivery experience and pregnancy 
outcome are likely to bias maternal recall (90). 
 
 
8 Prevalence of macrosomia 
Newborn macrosomia is an increasing obstetric challenge worldwide. It seems closely related 
to the current epidemics of obesity, found both in the westernized parts of the world and the 
developing countries. In Norway the prevalence of macrosomia is high, and the prevalence of 
newborns weighing 4000g or more has increased from 16% in 1968 to about 20% in 2006 (1).  
The percentage of newborns with high birth weight has been reduced the last ten years in 
Norway but the variations across the country are high. In Oslo, 15% of the newborns weighed 
4000g or above in 2006, whilst in Nord-Trøndelag 23% of the newborns weighed more than 
4000g. At the same time period there has been a significant decrease in infants born after 
gestational week 41 or 42 (1). This is illustrated in Figure 2. Some possible explanations have 
been suggested, but systematic investigations are lacking. There might have been a shift in 
obstetric management, reducing the macrosomic infants by identifying the rapid growing 
fetuses by ultrasound. The number of immigrants is higher in Oslo than in other parts of the 
country, especially from south Asia. In average, their infants weigh approximately 300g less 
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than Norwegian newborn (105). In addition, the urban population may have life style factors 
that differ from women in rural Norway.  
 
Figure 2 a 
Birth weight above 4000g and 4500g in different counties in Norway (from Medical Birth Registry (1)) 
Birth weight > 4000g                                   
 
 
  Birth weight > 4500g 
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Figure 2 b 
Gestational age above 41 weeks and 42 weeks in different counties in Norway (From Medical Birth Registry (1)) 
 
Gestational age > 41 weeks    
                                    
 
Gestational age > 42 weeks 
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8.1 Definitions of macrosomia 
There are no existing international or national definitions of a macrosomic newborn. 
Commonly used definitions are based on birth weight in grams. Suggested cut-points for the 
macrosomic definition are newborn weight above 4000g, 4500g or 5000g (106). These cut-
points seem random, referring to a “round number”, as a multiply of five or 10. Similarly, cut-
points based on observed percentiles have been suggested. Birth weight above the 90th or 95th 
percentile is used to define LGA. Correspondingly, SGA is defined as birth weight below the 
10th percentile, whereas those between 10th and 90th percentile are average for gestational age 
(AGA). Relative birth weight (ponderal index; weight/length 3) is another method to evaluate 
newborn body composition. One consequence is that various definitions of macrosomia and 
various cut-points have been used in different studies, which make comparison difficult (107). 
However, there is an increasing focus of the infant’s body composition rather than birth 
weight (13). Birth weight alone may be a too crude measure of anthropometric and metabolic 
features of relevance for short and long term health of the newborn.  
 
 
9 Consequences of macrosomia 
Giving birth to a macrosomic newborn include short- and long-term consequences for both 
the mother and the newborn infant.
9.1 Maternal health consequences, short term risks 
Unexplained intrauterine death is often associated with fetal macrosomia (108). Women 
delivering macrosomic infants more often experiences a number of adverse birth outcome 
(109-112) and prolonged labor (110). Prolonged second stage of labor may increase the risk 
of postpartum hemorrhage (113), the incidence of acute cesarean section (114) or vaginal 
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operative delivery (111). Delivering of a macrosomic fetus also increases the risk of third or 
fourth degree lacerations (110). It has recently been shown that the use of epidural analgesia 
(EDA) as pain relief during labor is associated with high birth weight (115). As both the use 
of EDA and macrosomic infants are associated with prolonged labor this needs to be 
investigated further. 
 
9.2 Maternal health consequences, long term risks 
Long term maternal consequences related to the delivery of a macrosomic fetus must be seen 
in relation to the actual delivery. A number of women develop post traumatic stress symptoms 
post partum, and it seems that obstetric interventions increase the prevalence (116). Serious 
complications in nulliparous may have consequences in regard to reproductive health. Some 
women suffer persistent perineal defects and urinary and anal dysfunction after perineal 
lacerations (111).  
 
9.3 Neonatal health consequences, short term risks 
Newborn macrosomic infants are associated with traumas such as shoulder dystocia, 
clavicular fracture, hypoglycemia and hyperbilirubinemia, and are therefore more often 
transferred to neonatal intensive care unit after birth (111;117). Immediate skin-to-skin 
contact between the mother and infant promotes breastfeeding initiation and duration and 
strengthens the maternal attachment behavior (118). 
 
9.4 Neonatal health consequences, long term risks 
High birth weight is related to obesity and the metabolic syndrome in adult life (63;119). 
Being born macrosomic by a mother with a high BMI often in a combination with GDM or 
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T2DM increases the risk of developing T2DM in early life of the offspring (120). Especially 
for young females this may influence later reproduction (96). 
 
 
10 Causes of macrosomia 
Birth weight is a measure of fetal growth, and is a composite of many components including 
bone, internal organs, muscle, fat and fluids. These may be determined both by genetically 
and environmental regulatory mechanisms (121). The genetic part probably plays a small role 
in the recent change in birth weight distribution, because genetic changes will take 
generations to affect birth weight. Prediction and explanation of the increasing prevalence of 
macrosomia have been subjected to a number of studies (13;53;117;122-128). The causes are 
multifactorial, and the cause may somewhat schematically be divided into non-modifiable and 
modifiable explanations.  
 
10.1 Non-modifiable explanations 
Among the known non-modifiable variables influencing birth weight is maternal age, parental 
birth weight, parity, gestational age and gender of child (117), although it has been shown that 
maternal age has less impact when controlled for parity (13). Genetics and transgenerational 
inheritance has also shown to have impact on birth weight, but to which extent has not been 
clearly clarified (129-131).  
10.2 Modifiable explanations 
Of the modifiable variables we find maternal anthropometry such as pre-gestational weight, 
BMI, body composition and gestational weight gain (53;98;125;126;132-135). Smoking is 
well documented as reducing birth weight (136;137). The level of physical activity may also 
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be associated with birth weigh (138), intake of nutrients (both macro-and micronutrients) and 
metabolic parameters (139-141). Pre-gravid BMI predicts fetal weight and macrosomia 
(13;20;142), as well as weight gain during pregnancy (30;143).  
10.3 Prevention or treatment of macrosomia? 
The body composition of the newborn probably also plays an important role. This is related to 
the maternal body composition, such as maternal birth weight, height and weight, weight gain 
and subcutaneous fat. The endocrine intrauterine environment also affects body composition, 
though much less is known of the impact of the glucose an insulin metabolism, as well as 
inflammatory factors. 
10.4 Identifying macrosomia 
In the discourse of the delivery of macrosomic infants the focus is often on the detection of 
macrosomia. The methods used may be either clinical or ultrasound estimations, and in most 
cases the clinical estimation is about as accurate as those derived from ultrasonography. The 
accuracy by two-dimensional ultrasound seems to predict birth weight up to 3500g pretty well 
(144). The problem arises, however, when the fetus is getting larger. Increased maternal BMI 
has shown to be associated with reduced accuracy in estimating fetal weight by ultrasound 
(145). It is thought that by identifying the macrosomic fetuses, birth outcome would improve. 
However, induction of labor for suspected macrosomia in non-diabetic women appears to 
increase the Cesarean Section (CS) rate, without improving perinatal outcome (146). 
Prevention of macrosomia would therefore be the best way to avoid the birth complications 
associated with the delivery of a large infant.  
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11 The current study 
11.1 Study design
The study followed a prospective cohort design. However, a retrospective assessment of 
physical activity was chosen. The inclusion period was from 2002 to 2005, and the cohort 
consists of 553 pregnant women and their newborns.  
Definitions: Macrosomia was defined as birth weight  4200g. Gestational age was based on 
ultrasound at weeks 17 – 19. 
11.2 Characteristics of the cohort 
Healthy pregnant women of Scandinavian heritage booked for birth place at Rikshospitalet, 
Oslo University Hospital were invited to participate in the study. Women with multiple and 
pre-gestational diabetes were excluded.  
About 2000 invitations were sent out; five hundred and eighty-eight women attended the 
study. Of these, 16 were excluded due to fetal malformations, duplex or spontaneous abortion 
and 19 were lost to follow up delivering at another hospital or moving out of the area. The 
participants were subjected to a scheduled prospective follow up, with four visits during 
pregnancy (Table 2). The first visit was conducted between gestational week 14-16 (visit 
one). Maternal anthropometric measures considered to be potential predictors of macrosomia 
were collected at each visit. Weight (kg) without shoes and heavy clothes was measured on a 
digital scale, followed by calculation of BMI. Subcutaneous fat was estimated using a Holtain 
calliper (Holtain, Crymych, UK).  
A standard oral glucose tolerance-test with 75 g glucose after 10-12 h fasting was performed 
twice (visit one and three). At visit one and three the participants filled out a self-administered 
quantitative food frequency questionnaire. Intake of macronutrients during pregnancy was 
calculated as the mean of the values obtained at visit one and three.  
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Physical exercise was assessed by a questionnaire. It was handed out at gestational weeks 32 
and collected at weeks 36, describing physical activity before pregnancy at each trimester. 
 
Table 2:  Design and follow up through pregnancy 
 
 Weeks of gestation 
Investigation Visit 1 Visit 2 Visit 3 Visit 4 
 14 -16 22 – 24 30– 32 36 - 38 
General follow up * + + + + 
Glucose tolerance test +  +  
Fasting blood samples † + + + + 
Fetal ultrasound ‡    + + + 
Food intake §   +  +  
Physical activity   * * * + 
 
*  Including blood pressure, weight, sub-scapular skin folds 
†  Serum EDTA, citrate plasma and buffy coat for immediate freezing at -70° C 
‡  Fetal growth rate assessed by ultrasound and Doppler flow profiles in the uterine and umbilical arteries 
§  Food frequency questionnaire 
 Level of physical exercise pre-gestational and at each visit was obtained by a questionnaire    answered at visit 
4. 
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12 The overall aim 
The overall aim of the present study was to extend insights into modifiable determinants of 
fetal overgrowth as reflected in newborn macrosomia and related delivery complications 
 
Paper 1: 
In this study we particularly wanted to investigate the effect of maternal body mass, fasting 
glucose values and physical inactivity on the risk of newborn macrosomia. In previous studies 
it has been questioned whether BMI and plasma glucose are independent determinants of 
newborn macrosomia. The role of physical activity was by large unknown. 
Main hypothesis: Physical inactivity, body mass index and plasma glucose play an 
independent role in determining newborn macrosomia 
 
Paper 2: 
As delivery complications are associated with newborn macrosomia, we also set out to 
investigate the role of determinants of macrosomia on delivery complications. 
We therefore investigated if physical inactivity has an independent effect on birth outcome 
besides contributions by other modifiable factors, including nutritional intake, plasma glucose 
levels, and maternal weight gain. 
Main hypothesis: Physical inactivity before and or during pregnancy is associated with 
delivery complications. 
 
Paper 3: 
In the general non-diabetic population it is not well understood why some women with high 
BMI give birth to macrosomic newborns while others do not. Given the central role of glucose 
in mediating fetal overgrowth in GDM and the metabolic continuum between individuals 
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with and without GDM, we wanted to explore the effects of change in fasting plasma glucose, 
insulin and insulin resistance in different body mass index groups on the risk of newborn 
macrosomia in a population of pregnant women who did not develop insulin-dependent 
GDM. 
Main hypothesis: The effect of gestational rise in fasting glucose on the risk of newborn 
macrosomia is dependent on maternal body mass index. 
 
Paper 4: 
There is some evidence that determinants of birth weight have different effects on the sexes. 
We therefore wanted to examine whether parental anthropometrics, parental birth weight and 
fasting maternal plasma glucose levels influence birth weight differently in the two sexes. 
Main hypothesis: Maternal and paternal determinants of birth weight have different effects in 
the two sexes. 
 
 
13 General discussions 
13.1 Main endpoints 
13.1.1 High birth weight 
The main outcome in this study has been high birth weight (macrosomia). The choice of using 
absolute birth weight and not relative birth weight was based on two arguments. First, birth 
weight gives newborn size which is more closely related to delivery complications than 
measures of relative birth weight. Secondly, current evidence indicates  that among newborn 
anthropometric parameters birth weight is a better predictor of adolescent fat distribution than 
is relative birth weight (147). Furthermore, reduced relative birth weight show a poorer 
association with fat mass in newborn than does birth weight (148).  
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Dual energy X-ray absorptiometri (DXA), first developed for assessment of bone mass, 
provides information on total fat mass (FM) and fat-free mass (FFM) or “lean” soft tissue, and 
their distribution in the trunk and upper limbs(149-151). Over the past decade, DXA has been 
increasingly used to assess body composition in research and clinical practice, including 
applications to direct treatment (152;153). DXA is generally accepted as a precise 
noninvasive technique to assess body composition in vivo, and there is a large quantity of data 
about the method in adults (154-158). Body composition would have been a potentially 
important supplement to birth weight in the current study. However, DXA-measurement of 
newborns was not available at the start of the project. Besides birth weight, fetal body 
composition near term, especially percent body fat, may be an independent determinant of 
delivery complications. This notion is supported by the fact that at any given birth weights, 
infants born by diabetic women have higher risk of shoulder dystocia. The rise in birth weight 
the last generation may also have been accomplished by an increased percentage of body fat. 
Interestingly, it has been registered that in a general obstetric population the need for 
operative delivery at a given birth weight was markedly increased from the 1990’s as 
compared to the 1940’s (3). Further studies should therefore take into consideration the role of 
body composition for birth complications. 
13.1.2 Delivery complications
Normal birth may be described as spontaneous onset of labor with a normal progression 
without drugs and spontaneous delivery. There seems be no generally accepted definitions of 
birth complications. In our study we have chosen CS (emergency and elective), operative 
vaginal delivery (forceps and/or vacuum extraction), severe haemorrhage ( 1000 ml) or 
perineal laceration of third or fourth degree as definitions of birth complications. The choices 
have been based upon clinical practice. We have only included term deliveries in the analyses, 
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and the inclusion criteria excluded mothers with severe diseases or diabetes and multiple 
pregnancies. Apart from preterm deliveries, we have included all the women in the study 
group in the analyses, including those with pregnancy complications. Some of these may have 
been chosen for induction of labor or elective cesarean section. It is well known that obstetric 
interventions in labor tend to lead from one to another (159).  
 
13.2 Methodological considerations 
13.2.1 Is the cohort representative? 
The population in this study is extracted from the women offered delivery service at 
Department of Obstetrics and Gynecology, Rikshospitalet University Hospital. Around two 
thousand women give birth at the hospital every year. We selected women with a 
Scandinavian background, and excluded women with known pregestational diabetes, serious 
heart, gastrointestinal, pulmonary or renal disease, as well as multiple pregnancies. The 
women asked to participate in the study were chosen “randomly” from the booking list 
without any selection beyond the exclusion criteria. The number of inclusions per month had 
to be adjusted according to logistic frames of the study. Thus, approximately five women 
could be included each week. Due to these limitations, we could not invite all the eligible 
women to participate in the study. Around one third of the women approached accepted the 
invitation. These circumstances might have caused a selection bias.  
We therefore compared the women delivering at Rikshospitalet, Oslo University Hospital who 
declined participation with the women accepting. We found that age, parity, work load and 
education were equal in the two groups. The women in the study group were slightly heavier 
around conception time, but they gained less weight throughout pregnancy than the non-
participants. We also compared the women in the study with a randomly sampled group of 
Scandinavian women at another University clinic in Oslo (Ullevål, Oslo University Hospital). 
 38
The study group and the Ullevål group were comparable except that the prevalence of single 
mothers and women smoking during pregnancy were slightly higher at Ullevål, Oslo 
University Hospital. 
This information makes us to assume that the cohort is fairly representative for an urban 
Norwegian population. However, the higher maternal age and education level presumably 
makes the current cohort to deviate from a rural population in Norway.  
 
13.3 Data collection 
13.3.1 Assessment of physical activity, the questionnaire 
A self-reporting questionnaire (Physical Activity and Pregnancy Questionnaire (PAPQ)) 
designed by The Norwegian School of Sport Sciences was used for this study. When the study 
started, no validated questionnaires for pregnant women existed to our knowledge. There are 
few reports and limited knowledge about level of physical activity or exercise during 
pregnancy. One aim was therefore to assess level of total physical activity (at work, in 
transportation, household and recreational exercise), both pre-gestational and trimester-
specific (100). The questionnaire was distributed at gestational weeks 32, and returned at 36 
weeks of pregnancy. It may be argued that the physical exercise data were obtained 
retrospectively in a study with a prospective design. The pre-gestational data had, however, to 
be obtained retrospectively, anyway, which made us choose a retrospective method for all the 
physical activity data.  
To our knowledge, there has not been performed many studies where exercise data was 
assessed prospectively before pregnancy. When planning the study, the general assumption 
was that physical activity during pregnancy would have greater impact than pre-gestational 
exercise had. We therefore chose to ask the women while pregnant to secure the data during 
pregnancy, rather than after delivery. 
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13.3.2 Maternal body mass index and fat mass 
In this study we have obtained maternal anthropometric parameters to describe body 
composition. At each visit every women was weighed on the same scale, in addition to 
sampling anthropometric measures with a caliper from three sites of the body (sub scapular, 
triceps and iliac crest). Height was self reported. In a subgroup of 26 women we measured 
their heights after reporting, and the correlation was r p = 0.96. In the analyses we have chosen 
to use BMI. This is a common and well known method, and the results were almost identical 
when we used the parameters from the calipers in the analyses. BMI is a crude method of 
describing body composition, as muscle mass and fat mass are not discerned. Studies of adults 
in the normal to mildly obese BMI ranges have shown that the relationship between BMI and 
percent body fat differs by age and gender. One longitudinal study, however, has determined 
the relationship between BMI and percent body fat in overweight/obese women (BMI > 25) 
before and during pregnancy. The correlation between BMI and percent body fat remained 
significant during pregnancy. However, the correlation weakened as the pregnancy advanced 
(160). In the current study BMI was assessed at 14-16 weeks as pregestational BMI could not 
be obtained with sufficient validity. 
13.3.3 Food frequency questionnaire 
The questionnaire was evaluated for a Norwegian population in 1997 and found suitable 
(161). However, it has not been tested on a pregnant population, but at the time when the 
study started there was to our knowledge not any such questionnaire available. Food habits 
have changed the recent years, and some of the responders commented that it did not quite 
cover their diet. However, energy intake and intake of macronutrients may no have changed to 
the extent that is the case with food items.  
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13.3.4 Newborn birth weight 
All the newborn children were weighed within two hours in the delivery room by the 
attendant midwife or the assistant. The scales are identical and regularly calibrated. This is a 
well established routine at the ward. Thus the assessment of the main endpoint, birth weight is 
considered valid. 
13.3.5 Fasting plasma glucose and insulin 
The women came for four antenatal visits during pregnancy in the early morning starting with 
drawing blood samples after an overnight fast. At gestational weeks 14-16 and 30-32 FPG 
were measured. A standard oral glucose tolerance-test with 75g glucose after 10-12 h fasting 
was performed twice (visit one and three). Plasma glucose was measured immediately in 
EDTA blood, venous, by Accu-Check glucose test strips and glucometer (Roche Diagnostics, 
Basel, Switzerland). Fasting plasma insulin values (FPI) were measured at weeks 14-16, 22-
24, 30-32 and 36-38. Samples were collected in 7 ml Vaccutainer tubes, centrifuged without 
delay at room temperature at 3000 G for 10 min. Serum was aliquoted immediately and stored 
at -80 ºC until analyzed. Insulin samples were assayed in duplicate (RIA, DPC, Los Angeles, 
CA, USA) and the intra- and inter-assay CV were 4.9% and 5.4%, respectively. Insulin 
resistance (HOMA-IR) was calculated by the equation presented by Matthews’s et.al. (162) 
and validated by Kirwan et.al (163) in a pregnant population ((FPG * FPI) / 22.5). 
 Due to the large scale of this study, we chose to measure glucose with a glucometer validated 
in tests in our clinic against standard laboratory methods. We are aware that glucometers 
formerly demonstrated low reproducibility of results, however in recent years the test quality 
has improved considerably (164;165).  
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14 Discussion of the results: 
14.1 Statistical considerations
In this study, we have followed the tradition of dichotomizing continuous variables, 
presenting the results in multiple regression analyses. As cut-off points we have used clinical 
experience and traditional cut-off points.  
1. Birth weight: There are no clear definitions of macrosomia, the most common cut-
offs are 4000g or 4500g, or above the 90th or 95th percentile of the population. Mean 
birth weight and the prevalence of small and large for gestational age vary strongly 
about different populations. SGA is often defined as birth weight below the 10th 
percentile. The 90th percentile in Norway has the past five years been approximately 
4200g (106). The risk of delivery complications increases when birth weight reaches 
the range of 4200-4500g (111). 
On this background birth weight  4200g was chosen as definition of macrosomia in 
the current study.   
2. Body mass index: Median BMI in this study was approximately 25 women with BMI 
> 25 are classified as overweight (WHO), and this was a natural cut-off point. 
3. Plasma glucose: The glucose values are measured to identify possible gestational 
diabetes and high birth weight. Accumulating data indicate that there is a continuous 
(none-brake point) relation between plasma glucose and obstetrical complications 
(HAPO)(56). We also had an interest in evaluating the pregnant women with high 
glucose values, but below the definition of diabetes. We therefore chose to use 
quartiles, comparing the upper quartile group with the rest. 
4. Pathological post partum haemorrhage in Norway is defined as bleeding above 500 
ml. It is usually estimated visually, an inherently inaccurate method. By choosing 
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1000 ml as a cut-off, we considered it less likely to include women with normal post 
partum blood loss.  
5. Physical activity: Often physical activity is measured in METS (metabolic equivalent 
task). Our questionnaire did not allow conversion into METS. But by combining the 
answers of the questions 1) How often do you exercise (times per week), and 2) For 
how long do you usually exercise (minutes)?, information of the mean weekly time 
spent on physical exercise was obtained. Women exercising less than 1 hour/week 
were defined as physically inactive. 
 
Clinical research has a tradition of converting continuous variables into categorical variables 
by grouping the values into two or more categories, while in epidemiological studies it is 
customary to create several categories or continuous variables (107).  
Data which are subjected to clinical decisions during a project constitute methodological 
challenges. Especially in paper 2 selection mechanisms caused by decisions of elective and 
acute CSs, makes analysis of confounding factors a complex task. It can not be ruled out that 
possible confounders might have contributed to the results if they were to be considered at a 
later stage in the process. This is illustrated by the notification about effect of macrosomia on 
operative vaginal deliveries. However, this counterfactual way of thinking was considered 
beyond the scope of this work.  
 
14.2 Physical activity 
Paper 1 and paper 2 
The relation between size at birth and level of maternal physical activity is not straightforward 
(166). Most studies of relations between physical exercise and birth weight have actual weight 
as endpoint, and have mainly studied effect of physical exercise during pregnancy. The effect 
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of a given exercise regimen on actual birth weight depends upon several factors including 
type, frequency, intensity and time point in pregnancy (103;167).  
In the current study the participants were asked if they performed a certain level of physical 
exercise or not before and/or during pregnancy. By this definition about 1 in 10 women 
reported low level of exercise. The cut-off we used in this paper defined women exercising 
less than one hour per week as physically inactive. 
However, we also found an effect on macrosomia when a cut-off level of physical exercise at 
1.88 hours per week was used (unpublished data). Our findings indicate that being physically 
inactive before pregnancy is associated with increased risk of fetal macrosomia.   
Interestingly, we found no relationships between physical exercise before pregnancy and BMI 
at week 14 to 16 (p = 0.28). We did not find any effect of physical exercise during pregnancy 
on the risk of macrosomia. Clapp et al (166) have shown that both the timing and the type of 
exercise during pregnancy are important variables that influence the fetoplacental growth, and 
may accordingly influence birth weight.  The current study is another indication that timing of 
exercise relative to the gestational period may be a determinant of fetal size. The finding that 
high BMI and physical inactivity before pregnancy were independent determinants of 
macrosomia indicate that the metabolic status of the mother at the start of pregnancy may 
have significant influence on growth and fat deposition of the fetus (21). 
Although macrosomia was the endpoint of the current study we did also find a higher mean 
birth weight of the infants delivered by the women being physically inactive before pregnancy 
(3833g versus 3660g, p = 0.06) (unpublished data). Thus, also the mean birth weight of a 
population may be affected by the level of pre-gestational physical exercise. 
Evaluating physical activity with a questionnaire during week 32-36 has limitations.  
It is, however, unlikely that there has been a recall bias among women who delivered 
macrosomic newborns or later suffered perineal lacerations, i.e. that these women reported 
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lower level of physical activity than they actually performed compared to the women who 
delivered macrosomic infants or with less risk of perineal lacerations.  
The mechanisms that may underlie the effect of physical inactivity can only be subject of 
speculations. Poor physical condition of the mother may reduce the capacity to push resulting 
in prolonged second stage which is associated higher risk of perineal lacerations (168;169). 
Physical inactivity may also be associated with poor function of the pelvic levator muscles 
resulting in insufficient rotational forces and prolonged second stage of delivery.   
 
14.3 Food frequency questionnaire 
The apparent absence of effect of energy and macronutrients should be interpreted cautiously 
as previous studies have shown effects of maternal diet during pregnancy on average birth 
weight (80-82;170). Consumption of carbohydrate with high glycaemic index seems to be 
associated with higher average birth weight. Its role in determining risk of fetal macrosomia 
is, however, unresolved. It may be argued that the study group consisted of a group of well 
nourished women, which will support the fetus of sufficient nutrients throughout pregnancy. 
This means that these fetuses never have been undernourished. Glucose passes freely across 
the placenta; the transport of amino acids and other nutrients is not that simple. We chose to 
analyze the macronutrients (fat, carbohydrates, protein and per cent of total energy), 
eliminating the micronutrients, knowing that this also may influence birth weight. We also 
selected to calculate mean values of macro nutrients, questionnaire answered at two different 
time points during pregnancy (visit one and visit three). Energy intake is closely related to 
energy expenditure. These are calculations we did not analyze.  
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14.4 Glucose values
We found that fasting glucose plasma values at week 30-32 predicted high birth weight better 
than the two hour oral glucose tolerance test (OGTT). This being the best predictor we 
therefore chose to use this parameter in the analyses. During the study period we realized that 
this was in accordance with other recent studies, which suggests that the fasting values are 
better predictors for high birth weight while two-hour OGTT better predicts the risk of 
developing diabetes later in life (40;56). 
 
 
15 Limitations of the study; internal and external validity 
Women have been asked to participate in a study that is quite time consuming. We do not 
have information about the reasons why some women declined to participate. This study can 
only give information about those who wanted to go through all the visits. It was confirmed 
by several women that being offered three extra ultrasound examinations motivated for 
participation. This is a study undertaken in one of the maternity hospitals in Oslo, where 
approximately 2000 newborn infants are born each year. As data from The Medical Birth 
Registry shows  there are variations throughout the country regarding both mothers and the 
newborn infants anthropometric measures and birth outcomes(1). This study encompasses an 
urban population. As mentioned above, the differences in maternal characteristics of the 
population in the study group and Ullevål University Hospital delivery unit, was similar. One 
may therefore assume that the results in this study are representative not only for the 
population studied, but also for women living within the same urban conditions. 
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15.1 Food frequency questionnaire 
The food frequency questionnaire was detailed and time consuming to fill in. Even though it 
was complicated and did not always cover their food habit, most women did. Only four 
participants did not hand it in at the first visit, and 41 failed to deliver it at the third visit. As 
the questionnaires were pre-numbered and to be read electronically they were not substituted 
if lost. 
 
15.2 Physical activity questionnaire 
The purpose of the physical activity questionnaire was to assess the total physical activity 
level of pregnant women, and to investigate the association between weight gain, physical 
activity and exercise during pregnancy, and to evaluate the influence of physical activity on 
newborn weight and pregnancy outcome. The questionnaire has now been validated with a 
portable activity monitor (ActiReg®, PreMed AS, Oslo, Norway), but not yet published (171). 
Seventy-seven pregnant women wore the ActiReg sensors during waking hours for seven 
consecutive days and answered the PAPQ. The results indicated only small differences 
between the PAPQ and the ActiReg in cross-tabulation of total physical activity level and 
proportion of participants meeting the current exercise guidelines. The study therefore 
concludes that there may be several advantages in combining these two types of instruments 
for registrations of physical activity level during pregnancy. Further studies may benefit from 
using both questionnaire and motion sensors.
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16 Summary of results 
1. Body Mass Index / fat mass 
We found the same results when using BMI or calculated fat mass assessed with caliper 
measures.  
 Women with BMI higher than 25 kg/m2  in early pregnancy have increased risk 
of delivering an infant weighing  4200g 
2. Weight and weight gain throughout pregnancy 
 Women gaining more than 10 kg from weeks 14-16 to 36-38 have increased 
risk of delivering an infant weighing  4200g 
3. Nutrition 
 There was no significant association between intake of fat, carbohydrates or 
protein and risk of delivering an infant weighing  4200g 
4. Plasma glucose 
 Fasting plasma glucose measured at weeks 30-32 gave the strongest 
association with the risk of delivering an infant weighing  4200g 
 Increasing fasting plasma glucose between weeks 14-16 and 30-32 in women 
with high BMI (BMI > 27 (upper quartile)) is associated with the risk of 
delivering an infant weighing  4200g 
5. Fasting plasma insulin 
 There were no significant association between fasting plasma insulin and the 
risk of delivering an infant weighing  4200g 
6. Physical inactivity before pregnancy (less than one hour/week) 
 Women who defined themselves as physically inactive before pregnancy had 
increased risk of delivering an infant weighing  4200g 
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 Women who were physically inactive before pregnancy increased the risk for a 
perineal laceration degree three or four. 
7. Birth complications 
 Significant predictors for induction of labor were parity, maternal age, 
gestational age and BMI 30. 
  High birthweight and high BMI were overrepresented among Cesarean 
Sections.  
 Emergency Cesarean Sections was associated with birthweight, parity, 
maternal age and induction of labor.  
 After excluding Cesarean Sections, operative vaginal delivery was associated 
with parity and gender. 
 Perineal laceration was associated with operative vaginal delivery and 
pregestational physical inactivity  
 Haemorrhage was associated with high birthweight and BMI 30.  
8. Sex differences 
• Maternal BMI in early pregnancy and weight gain in pregnancy is associated 
with both girls and boys birth weight. 
• Birth weight of girls is associated with maternal fasting plasma glucose at 
week30-32 and weight gain in pregnancy. No such association was significant 
in boys. 
• Birth weight of boys is associated with paternal birth weight. 
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17 Conclusive remarks 
The present work gives support to the notion that pre gestational metabolic conditions of the 
woman are important determinants of pregnancy and delivery complications. High body mass 
index and physical inactivity are according to the present work two such conditions both of 
which are clearly associated with energy metabolism. In particular, pre gestational physical 
activity has, to our knowledge, not been associated with risk of fetal macrosomia and perineal 
lacerations. The findings of the effect of pre gestational physical inactivity may have major 
impact in preventing obstetrical complications if confirmed in larger studies.  
The present study also points to the upcoming issue of diverting effects of determinants of 
birth weight and body composition between the sexes. 
It is well known that boys are heavier at birth than girls. After controlling for high birth 
weight and head circumference, we still found that boys are more often exposed to vacuum 
extraction than girls. We also found that girls and boys have different responses to maternal 
and parental parameters in relation to birth weight. 
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Appendix 

Kvinneklinikken 
Postadresse: 
0027 OSLO 
 
Besøksadresse 
Sognsvannsv.  
 
 
 
  
 
Til deg som er gravid og har fødeplass på Rikshospitalet 
Forespørsel om å delta i STORK-prosjektet 
(Maternelt metabolsk syndrom, store barn og svangerskapskomplikasjoner)
Stork-prosjektet søker å finne svar på hvorfor forekomsten av store barn er økende.  
Fra 1990 til 1999 har andelen av barn med fødselsvekt over 4kg økt fra 16 % til vel 20 %.
Dette er en uheldig utvikling. Det er kjent at store barn kan medføre økt risiko for mor og barn 
under fødselen.
Bakgrunnen for undersøkelsen er at vi ønsker å vite mer om hvorfor stadig flere 
kvinner føder store barn.  Det vil gi mulighet til å identifisere kvinner som har økt risiko for å 
føde stort barn tidlig i svangerskapet, og utvikle støttetiltak for å motvirke denne utviklingen. 
Det finnes i dag ikke noe entydig svar på hvorfor det nå fødes flere store barn.  Hos noen er 
det genetisk bestemt.  Andre faktorer som også trolig påvirker fosterets vekst, er kvinnens 
fysiske aktivitet, type og mengde mat hun spiser og omsetningen av sukker i blodet.  
Ved å delta i undersøkelsen vil du bli fulgt opp av en fast jordmor som er prosjektleder her på 
Kvinneklinikken.
Alle undersøkelsene er gratis, og du er forsikret på vanlig måte gjennom 
pasientskadeordningen.
Undersøkelsen er kun ute etter å samle informasjon og vil ikke ha noen påvirkning på 
svangerskapet eller barnet dittDet er helt frivillig å bli med i undersøkelsen.  Selv om du har 
begynt, kan du når som helst og uten grunn trekke deg.  Dine data vil da bli slettet og ikke 
brukt i undersøkelsen.
Undersøkelsene: 
Hvis du velger å delta, vil det bety fire kontroller på Rikshospitalet i løpet av svangerskapet.
Noen av disse vil kunne være i stedet for kontroller hos egen lege / jordmor. 
Hver gang møter du fastende, det betyr at du ikke skal spise eller drikke etter klokka 24.00.
Du får litt vann når du kommer. 
1. gang ved ca. 14-16 ukers svangerskapsvarighet
 Kostholdsskjema som du har fått i posten skal leveres 
 Fastende blodsukkerbelastning. Du får drikke 75 g. druesukker.  Deretter tas det 
blodprøve fire ganger (hver ½-time) for å måle hvordan kroppen reagerer på en viss 
mengde sukker. Vi setter inn en veneflon (et tynt plastrør) i en blodåre på armen, slik 
at det bare blir ett stikk. Prøven tar litt over to timer, så det er lurt å ta med lesestoff og 
evt. en matpakke til å spise like etterpå.  Svaret vil foreligge med en gang, og du vil få 
vite resultatet. 
2. gang ved 22-24 uker.
 Det blir tatt blodprøve til nedfrysing.  Det tar ca. 15 minutter. 
 Ultralyd av barnet for å måle vekst og trivsel.  Ultralydundersøkelsen vil også måle 
blodgjennomstrømningen i navlesnor og til livmoren.  Dette gir oss kunnskap om 
fosterets trivsel. 
3. gang ved 30-32 uker- 
 Sukkerbelastning som første gang, pluss 
 ultralyd som andre gang 
 nytt kostholdsskjema 
4. gang ved 36-38 uker 
 Blodprøver som andre gang, pluss 
 ultralyd som tidligere 
 fysisk aktivitetsskjema 
Det vil hver gang tas blodprøver som skal fryses ned.  Disse prøvene vil bli analysert først 
etter at hele prosjektet er gjennomført.   
 
Resultatene av undersøkelsen vil bli offentliggjort i godkjente tidsskrifter. 
Studien er vurdert av datatilsynet og regional etisk komite.
Med vennlig hilsen 
…………………..
Nanna Voldner 
jordmor / stipendiat 
Hvis du ønsker å være med i prosjektet er det fint hvis du så raskt 
som mulig gir en tilbakemelding til Kvinneklinikken. 
 
Du kan ringe til sekretær Tone Hassel 23 07 29 27 eller mobil 93 02 
22 54 og si at du skal være med i STORK-prosjektet og du kan få 
time over telefon. 
 
Du kan også sende en e-post til tone.hassel@rikshospitalet.no
og få time tilbake på mail. 
Spørsmål kan rettes til Nanna Voldner tlf: 23 07 29 26, mobil 99 73 
82 90  
eller på mail. nanna.voldner@rikshospitalet.no
 
Jeg har mottatt skriftlig informasjon om denne undersøkelsen og samtykker i å 
delta.
________
____________________________________________________ 
Dato           Underskrift 
Jordmors erklæring: 
Jeg bekrefter at kvinnen har fått skriftlig og muntlig informasjon om hva det 
innebærer å delta i prosjektet. 
________
_____________________________________________________
Dato              Underskrift (jordmor Nanna Voldner) 
Kvinneklinikken 
Postadresse: 
0027 OSLO 
 
Besøksadresse: 
Sognsvannsv. 20 
 
Sentralbord: 23 07 00 00 
Dir. linje: 23 07 26 30/40 
Telefaks: 23 07 26 50 
Deres ref: Org.nr. NO 970 897 771 
Vår ref:
Dato:
Takk for at du vil delta i STORK-prosjektet 
Du har fått time til undersøkelse ved KK føde poliklinikk 
Til deg som kommer 1. og 3. gang:
Du skal ta fastende blodukker på endokrinologisk lab. først.  Der åpner de litt før halv åtte, 
så du kan komme så tidlig hvis du vil, men helst ikke senere enn 8:15.  Prøven tar ca. to 
timer, og du må passe på å spise før du kommer på føde poliklinikk.  Du kan godt ta med 
matpakke. 
Til deg som kommer 2. og 4. gang:
Du skal ta en fastende blodprøve som tar kort tid, slik at du må komme på endokrinologisk 
lab. en liten stund før du har time.  Du bør også passe på å spise før du kommer på føde 
poliklinikken.
Endokrinologisk lab. ligger i 1.etasje i glassgaten.  Gå inn hovedinngangen, og mot venstre 
et lite stykke, så vil du se skilt på høyre side. 
Hvis tiden ikke skulle passe, ber vi deg vennligst gi beskjed på tlf: 23 07 46 47 
Vennligst henvend deg i poliklinikkens ekspedisjon i 3. etasje på Kvinneklinikken når du 
kommer dit, (avsnitt E2) både før og etter konsultasjonen. 
Velkommen
Vennlig hilsen for Kvinneklinikken 
p:\kvinnehelsesenteret\nv_stork_tilbudsbrev.doc 
Kode _________ 
SPØRRESKJEMA OM
GRAVIDITET OG FYSISK AKTIVITET 
Les dette nøye før du starter:
På de neste sidene følger noen spørsmål om fysisk aktivitet  
og helse. Velg den svarkategorien som passer best for deg 
og sett kryss. Dersom du markerer feil sett da en strek over   X  ,  
og sett et nytt kryss. Hvis det er noe du lurer på kan du spørre jordmor 
Nanna Voldner om hjelp.
Marker slik:  
IKKE slik :                 eller  
Dersom du markerer feil: 
                                    
                                             
                   Sett strek over den gale markeringen 
Før du går videre er det fint om du fyller ut dato nedenfor 
Dato: ______/______ 02 
             (Dag)     (Måned) 
BAKGRUNNSOPPLYSNINGER 
1.   Alder:            år 
2. Svangerskapsuke:  
3.   Hvilken sivilstand har du nå? 
         Gift/samboer                                            Enslig 
         Skilt/separert                                            Enke 
          
4.   Hva er din høyeste fullførte utdannelse? 
         Grunnskole                                              Høgskole/universitet inntil 4 år  
         Videregående yrkesfaglig                        Høgskole/universitet mer enn 4 år 
         Videregående allmennfaglig                    Annen utdannelse
5.   Yrke/stilling:  ....…………………………....................................................................................................... 
6. Hvor stor stillingsprosent har du?         
                                                                  Før                   Uke 1-12             Uke 13- 27             Uke 28-40 
                                                       graviditet         (1. trimester)        (2. trimester)         (3.trimester) 
100%
Mer enn 50% 
Mindre enn 50% 
Arbeidsledig
Sykemeldt   
             Jobber ikke (f.eks. student) 
7.   Hvilken arbeidstid har du på nåværende tidspunkt? 
         Fast dagtid                                               Skiftarbeid eller turnusordning 
         Fast ettermiddag/kveld                             Ingen fast ordning ( ekstrahjelp, vikar o.l.)               
         Fast nattarbeid                                         Jobber ikke (arbeidsledig, sykemeldt, student o.l) 
                                                                     
HELSE OG LIVSSTIL  
8.   Høyde:            m 
9.   Vekt før graviditet:           kg
10.   Er du tilfreds med vektøkningen du har hatt så langt? 
   JA                        NEI                       Vet ikke 
2
11.   Hvor mange kg har du lagt på deg? 
         -5-0 kg                                           16-20 kg 
         0-5 kg                                            20-25 kg 
                6-10                                               Mer enn 25 kg 
         11-15 kg                                            
12.   Hvordan vil du karakterisere kostvanene dine? 
                                    Svært bra          Bra            Middels         Dårlig       Svært dårlig 
Før graviditet 
             I dag
13 a) Røyker du daglig? 
         JA              NEI    
     b)   Hvis JA bes du svare så nøyaktig som mulig på antall sigaretter 
    .............. pr. dag 
     c)  Hvis NEI, har du røykt tidligere? 
         JA              NEI    
     d)  Er du utsatt for passiv røyking hjemme eller på arbeid? 
         JA              NEI    
14.   Hvor ofte drikker du alkohol? 
                                                                    Før                 Uke 1-12             Uke 13- 27              Uke 28-40 
                                                         graviditet       (1. trimester)         (2. trimester)        (3. trimester)
Sjelden eller aldri
Mindre enn 1 gang per måned 
1-3 ganger per måned 
1 gang i uka 
Flere dager i uken  
             Hver dag
HELSEPLAGER 
15 a)   Har du problemer urin-lekkasje? 
         JA              NEI   
3
     b)   Hvis JA, når skjer dette? 
                                                                       Før                Uke 1-12             Uke 13- 27           Uke 28-40 
                                                            graviditet       (1. trimester)       (2. trimester)       (3. trimester)
Når jeg er fysisk aktiv 
Når jeg hoster og/eller nyser 
Når jeg ler 
Ved sterk vannlatingstrang 
16 a)   Har du problemer med å holde på luft eller avføring?  
         JA              NEI    
     b)  Hvis JA, når skjer dette? 
                                                                       Før                Uke 1-12             Uke 13- 27           Uke 28-40 
                                                            graviditet       (1. trimester)       (2. trimester)       (3. trimester)
Når jeg er fysisk aktiv 
Når jeg hoster og/eller nyser 
Når jeg ler 
Når jeg må veldig på do 
17 a)  Hvor ofte har du avføring? 
                                                                       Før                Uke 1-12             Uke 13- 27           Uke 28-40 
                                                            graviditet       (1. trimester)       (2. trimester)       (3. trimester)
 Mindre enn 2 ganger per uke 
 Annenhver dag 
 Hver dag 
 Flere ganger per dag 
b) Må du ”trykke” for å få ut avføring?
         Sjelden eller aldri                                     Ofte
         Av og til                                                    Alltid 
                
18 a)   Har du i løpet av dette svangerskapet vært plaget med smerter i bekkenområdet (bekkenløsning)?  
         JA              NEI   
4
     b)   Hvis JA, har du hatt så store vansker med å gå at du må bruke stokk eller krykker? 
                                                                       Før                Uke 1-12             Uke 13- 27           Uke 28-40 
                                                            graviditet       (1. trimester)       (2. trimester)       (3. trimester)
 Ikke i det hele tatt 
 Ikke så ofte 
 I perioder 
 Mesteparten av tiden  
19 a)   Har du i tidligere svangerskap vært plaget med smerter i bekkenområdet (bekkenløsning)? 
         JA              NEI    
     b)   Hvis JA, når sluttet plagene? 
         Mindre 6 uker etter fødselen                5-10 måneder etter fødsel 
          6-20 uker etter fødselen                      Har fortsatt vedvarende plager                
JOBBAKTIVITETER 
Dersom du i dag ikke har jobb eller betalt arbeid utenfor hjemmet, vennligst gå videre til  
spørsmål nr. 26 a) 
20.   Arbeider du stående og/eller gående? 
         Sjelden eller aldri                                        JA, mindre enn 50% av tiden 
         Av og til, men ikke daglig                            JA, mer enn 50% av tiden 
              
21.   Arbeider du med armene løftet i skulderhøyde eller høyere? 
   Av og til, men ikke daglig                            JA, mer enn 50% av tiden 
22.   Må du vri eller bøye deg mange ganger i løpet av en arbeidsdag? 
         Sjelden eller aldri                                        JA, mindre enn 50% av tiden 
         Av og til, men ikke daglig                            JA, mer enn 50% av tiden 
23.   Hvor ofte opplever du belastende løft på arbeidsplassen? 
         Sjelden eller aldri                                     10-20 ganger daglig  
         Mindre enn 20 ganger ukentlig                Mer enn 20 ganger daglig 
         Mer enn 20 ganger ukentlig
5
24.   Vil du karakterisere jobben din som fysisk krevende? 
         JA, spesifiser .............................………………………....................…............................................... 
         Av og til, spesifiser ................................................................…………………………........................
         NEI, spesifiser .............................................................................................…………………………..
TRANSPORTAKTIVITETER 
25 a)  Hvordan kommer du deg vanligvis til jobb nå som du er gravid? 
         (Sett gjerne flere kryss dersom mer enn et av alternativene passer)
         Kjører bil                                                  Går
         Offentlig kommunikasjon                         Annet, spesifiser ...................................…………………...
               Sykler
     b)  Hvor lang tid bruker du til og fra hjem og arbeidssted (en vei)?
         Mindre enn 5 min                                     30-60 min 
         5-15 min                                                   Mer enn 60 min  
         15-30 min                                                 Annet, spesifiser ....................................………………….
26 a)   Har du barn du skal bringe/hente? 
         JA, daglig                                                 JA, av og til 
               JA, annenhver dag                                   NEI 
     b)  Hvis JA, hvordan bringer/henter du vanligvis barna nå som du er gravid? 
          (Sett gjerne flere kryss dersom mer enn et av alternativene passer)
         Kjører bil                                                  Går
         Offentlig kommunikasjon                         Annet, spesifiser ...................................…………………...
               Sykler
27 a)  Kan du angi hvor mye du totalt går (bruker bena) i løpet av en dag (utenom arbeidstid)?  
  (F.eks. til og fra arbeid,  hente/bringe barn, til og fra butikken, osv.)
         Mindre enn 5 min                                     30-60 min 
         5-15 min                                                   Mer enn 60 min  
         15-30 min                                                 Går sjelden eller aldri 
     b)  Er dette mindre tid enn du normalt ville brukt bena (gått) dersom du ikke var gravid? 
         JA              NEI    
28 a)  Kan du angi hvor mye du totalt sykler i løpet av en dag?
  (F.eks. til og fra arbeid, hente/bringe barn, til og fra butikken, osv.) 
         Mindre enn 5 min                                     30-60 min 
         5-15 min                                                   Mer enn 60 min  
         15-30 min                                                 Sykler sjelden eller aldri 
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    b)  Er dette mindre tid enn du normalt ville brukt dersom du ikke var gravid? 
         JA              NEI    
29 a)  Bruker du trapper fremfor heis/rulletrapp? 
         JA                           Av og til                NEI             
    b)  Ville du brukt mer trapper dersom du ikke var gravid? 
         JA              NEI    
AKTIVITET I HJEM OG NÆRMILJØ 
30 a)  Har du barn fra før? 
         JA              NEI    
    b)  Hvis JA, hvor mange barn under 18 år har du omsorg for? 
         1                2                3                 4 eller flere 
31 a) Har du hage/gårdsplass? 
         JA              NEI   
    b) Hvis JA, hvor ofte i en vanlig uke gjør du tungt fysisk hagearbeid eller tilsvarende? 
         (F.eks. snømåking, klippe plenen, løfte tunge steiner, hugge ved, gravearbeid, oppussingsarbeid) 
                                                                  Før                   Uke 1-12             Uke 13- 27             Uke 28-40 
                                                       graviditet         (1. trimester)        (2. trimester)         (3.trimester) 
Aldri        
Mindre enn 1 gang i uka 
1-3 ganger i uka 
3-5 ganger i uka
Hver dag        
             Mer enn 1 gang per dag
7
  c)  Hvis JA, hvor ofte i en vanlig uke gjør du lett til middels anstrengende hagearbeid eller tilsvarende? 
         (F.eks. bære lette ting, rydde, vedlikeholdsarbeid, luke i blomsterbed, koste og rake) 
                                                                  Før                   Uke 1-12             Uke 13- 27             Uke 28-40 
                                                       graviditet         (1. trimester)        (2. trimester)         (3.trimester) 
Aldri        
Mindre enn 1 gang i uka 
1-3 ganger i uka 
3-5 ganger i uka
Hver dag        
             Mer enn 1 gang per dag
32.   Hvor ofte i en vanlig uke gjør du med lett til middels anstrengende arbeid i hjemmet? 
        (F.eks. støvsuge, vaske gulv, trappevask, innkjøp av mat, pleie og omsorgsoppgaver) 
         
                                                                  Før                   Uke 1-12             Uke 13- 27             Uke 28-40 
                                                       graviditet         (1. trimester)        (2. trimester)         (3.trimester) 
Aldri        
Mindre enn 1 gang i uka 
1-3 ganger i uka 
3-5 ganger i uka
Hver dag        
             Mer enn 1 gang per dag
33.   Hvor fysisk anstrengende er dine daglige omsorgsoppgaver og gjøremål i og rundt hjemmet? 
         Veldig lett                                                 Anstrengende                    
         Lett                                                           Svært anstrengende  
         Litt anstrengende                                                  
FRITIDSAKTIVITETER; SPORT OG REKREASJON 
MERK: Fysisk aktivitet defineres som 1 eller flere treningsaktiviteter per uke         
             med minst 20 minutters varighet per gang 
34.   Var du regelmessig fysisk aktiv før graviditet? 
(1 eller flere mosjonsaktiviteter per uke med minst 20 minutters varighet per gang) 
         JA              NEI    
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 35.   Er du som gravid regelmessig fysisk aktiv? 
 (1 eller flere mosjonsaktiviteter per uke med minst 20 minutters varighet per gang)
                                                                                   JA                   NEI 
1-12 svangerskapsuke (1. trimester)        
13-27 svangerskapsuke (2. trimester) 
28-40 svangerskapsuke (3. trimester) 
    Dersom du har svart NEI på både spørsmål 34 og 35, vennligst gå videre til spørsmål nr. 43 
36.   Hvor lenge har du drevet med regelmessig fysisk aktivitet før nåværende svangerskap? 
(1 eller flere mosjonsaktiviteter per uke med minst 20 minutters varighet per gang)
         Mindre enn 6 måneder                             5-10 år 
         6 mnd -1 år                                              Mer enn 10 år
         1-4 år 
37. Har du opprettholdt samme fysisk aktivitetsnivå som før graviditet? 
                                                                                           Mer aktiv            Like aktiv             Mindre  
                                                                                         før graviditet         som før              aktiv nå
1-12 svangerskapsuke (1. trimester)        
13-27 svangerskapsuke (2. trimester) 
28-40 svangerskapsuke (3. trimester) 
38. Hva slags type fysisk aktivitet driver du vanligvis? (Sett maks tre kryss)
                                                                             Før              Uke 1-12             Uke 13- 27            Uke 28-40     
                                                                  graviditet       (1. trimester)       (2. trimester)      (3. trimester)
Går tur
Jogger / løper 
Svømmer
Sykler  
Styrke / vekttrening 
Ballsport
Langrenn / rulleski 
Skøyter / rollerblades 
Kampsport
Aerobic 
Aerobic for gravide 
Bevegelighetstrening / avspenning 
Dans 
             Annet 
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39.   Hvor ofte driver du med fysisk aktivitet? 
                                                                 Før                    Uke 1-12               Uke 13- 27          Uke 28-40 
                                                     graviditet            (1. trimester)         (2. trimester)      (3. trimester)
1 gang i uka        
 2-3 ganger i uka 
 4-5 ganger i uka 
 5-6 ganger i uka 
 Hver dag
       Mer enn 1.gang per dag 
40.   Hvor lang tid bruker du i gjennomsnitt når du trener? 
       (Ikke medregnet tid til skift, dusj, reisevei osv.) 
                                                                 Før                Uke 1-12         Uke 13- 27          Uke 28-40
                                                graviditet       (1. trimester)    (2. trimester)     (3. trimester) 
Mindre enn 30 min        
30-60 min 
1-2 timer 
Over 2 timer 
41.   På hvilken intensitet trener du vanligvis? 
                                                                     Før                  Uke 1-12            Uke 13- 27           Uke 28-40 
                                                          graviditet          (1. trimester)      (2. trimester)      (3. trimester)
Uten å bli svett eller andpusten 
(oppleves lite anstrengende)
Blir svett og lett andpusten 
(oppleves anstrengende )
Blir veldig svett og puster tungt 
(oppleves svært anstrengende)
42 a)  Gjør du 1 gang i uken eller mer styrkeøvelser på egenhånd hjemme? 
         JA              NEI    
    b)  Hvis JA, gjør du øvelser for disse musklene?                                                                                            
                                                                             Magemusklene         Ryggmusklene         Bekkenbunns- 
                                                                                                                                                             musklene                         
                                                                                                                             
Før graviditet        
1-12 svangerskapsuke (1. trimester) 
13-27 svangerskapsuke (2. trimester) 
28-40 svangerskapsuke (3. trimester)
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STØTTE, BARRIERER OG MOTIVASJON 
43.   Var det noen i din nære familie (mor, far eller søsken) som drev regelmessig fysisk aktivitet   
        under din oppvekst (før du fylte 18 år)? 
         JA              NEI    
44.   Hvor vanlig er det å drive fysisk aktivitet i din nærmeste omgangskrets? 
         Ikke vanlig             Forekommer           Svært vanlig 
45. Hvilket av disse alternativene passer best for deg? 
         Jeg trener ikke, og jeg har ikke tenkt til å begynne 
         Jeg trener ikke, men det er mulig jeg begynner 
         Jeg trener noen ganger, men ikke regelmessig 
                Jeg trener regelmessig, men har akkurat startet
                Jeg har trent regelmessig mer enn 6 måneder
46 a)   Trener du sammen med noen? 
   Aldri                      Av og til                Alltid                  Trener ikke 
       
     b)   Hvis du har svart alltid eller av og til, hvem trener du vanligvis med?
            (Sett gjerne flere kryss dersom mer enn et av alternativene passer)
         Familie/ektefelle/partner                        Idrettsklubb 
         Venner                                                   Helsestudio/aerobic (mennesker jeg møter der) 
               Arbeidskollegaer                                    Hund 
47. Dersom du i dag ikke er regelmessig fysisk aktiv, hva er de to viktigste grunnene til dette? 
        (Sett maks to kryss)
         Har ikke tid 
         Er ikke interessert 
         Får nok mosjon gjennom min jobb og/eller i hjemmet 
         Det krever for mye å komme i gang 
         Passer ikke med barn/omsorg 
   Har ingen å trene sammen med 
   Vanskelig å kombinere med arbeid/utdanning 
         Dårlige treningsmuligheter  
         Negative opplevelser i forbindelse med fysisk aktivitet 
         Svangerskapskomplikasjoner 
         Har aldri trent, ingen erfaring 
         Sykdom/handikap 
         Frykt/redsel for mitt ufødte barn 
         Helsepersonell råder meg til ikke å være fysisk aktiv 
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48.   Dersom du i dag er regelmessig fysisk aktiv, hva er de to viktigste grunnene til dette? 
        (Sett maks to kryss)
         Det er gøy/opplevelse 
         Gir bedre utseende/kropp 
         Avreagere/avkobling 
         Trener til større eller mindre konkurranser 
         Gir bedre fysisk form/forebygger helseplager 
         Gir psykisk overskudd/velvære/glede 
         Holde vekta nede (slik at jeg ikke legger for mye på meg under graviditeten) 
   Øker selvtilliten/selvfølelsen 
         Reduserer svangerskapsplager 
         Motvirker angst og depresjon 
         Fordi jeg føler at jeg bør 
         Det er sosialt 
49. Bekymrer du deg for barnet inne i magen når du driver med fysisk aktivitet? 
   JA                         Av og til                NEI                   Trener ikke 
50 a)  Har lege/jordmor gitt deg råd om hvordan drive fysisk aktivitet i svangerskapet? 
         JA              NEI    
      b)  Hvis JA, hvilke råd fikk du, vennligst spesifiser nærmere? 
        ………………………….............................................................................................................................. 
        ..................................…………………………............................................................................................ 
        .....................................................................…………………………......................................................... 
        ........................................................................................................…………………………......................
ROLIGE AKTIVITETER 
51. Hvor mange timer ser du på TV?
                                                 Hverdag                  Helg/fridag 
Mindre enn 1 time 
1-2 timer
2-3 timer 
3-4 timer 
             4-5 timer 
             Mer enn 5 timer 
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52.   Hvor lang tid bruker du på å lese bøker/aviser/blader, løse kryssord eller lignende? 
                                                 Hverdag                  Helg/fridag 
Mindre enn 1 time 
1-2 timer
2-3 timer 
3-4 timer 
             4-5 timer 
             Mer enn 5 timer 
53 a) Hvor mange timer sover du vanligvis i løpet av et døgn?
                                                                                             
                                                 Hverdag                  Helg/fridag 
Mindre enn 4 timer 
4-6 timer
6-8 timer 
8-10 timer 
            10-12 timer 
            Mer enn 12 timer 
      b)   Er dette mer tid enn du normalt ville sovet dersom du ikke var gravid? 
         JA              NEI    
TUSEN TAKK FOR HJELPEN 
Alle rettigheter reservert
Copyright 2002 Norges idrettshøgskole
Lene Annette Hagen
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HVA SPISER DU? 
 
 
 
 
I dette skjemaet spør vi om dine spisevaner slik de er nå. 
Vi er klar over at kostholdet varierer fra dag til dag. Prøv derfor  
så godt du kan å gi et ”gjennomsnitt” av dine spisevaner. Der du 
er usikker, anslå svaret.  
 
 
Skjemaet skal leses av en maskin, og det er derfor viktig at du  
setter et tydelig kryss i avmerket rute.  
 
Riktig markering er slik:  
 
Bruk helst bløt blyant. Feil kan da rettes med viskelær.  
Kulepenn og svart tusjpenn kan også brukes.  
 
Av hensyn til den maskinelle lesingen pass på at arkene ikke blir brettet.  
 
 
 
 
Alle svar vil bli behandlet strengt fortrolig.  
 
 
 
 
 
 
 
EKSEMPEL PÅ UTFYLLING AV SPØRSMÅL 1. 
Kari Nordmann spiser daglig 5 skiver brød og ett knekkebrød. 
Hun spiser vanligvis kneippbrød, men i helgene blir det en del 
loff. I tillegg spiser hun et knekkebrød hver dag. Hun fyller ut 
første spørsmål slik: 
 
 
 
1.  HVOR MYE BRØD PLEIER DU Å SPISE? 
 Legg sammen det du bruker til alle måltider i løpet av en dag. 
 (1/2 rundstykke = 1 skive, 1 baguett = 5 skiver) 
 
Sum skiver pr. dag = 5     
Antall skiver pr. uke:  5 x 7 = 35. Tallet brukes i spørsmål 5. 
 
1. HVOR MYE BRØD PLEIER DU Å SPISE?
Legg sammen det du bruker til alle måltider i løpet av en dag.
(1/2 rundstykke = 1 skive, 1 baguett = 5 skiver, 1 ciabatta = 4 skiver)
Antall skiver pr. dag
Fint  brød
(loff, baguetter, fine rundstykker o.l.)
Grovt brød
(fiberkneipp, mørk kneipp, mørkt hj. bakt o.l.)
Knekkebrød
(kavring, grov skonrok o.l.)
1/2 1 2 3 4 5 6 7 80
2.HVA PLEIER DU Å SMØRE PÅ
BRØDET?
Merk av både for hverdag og helg, selv
om du bruker det samme.
Hverdager Lørdager, søndager En porsjonspakning på 12 g
rekker til antall skiver
Bruker ikke
Smør (meierismør)
Bremykt
Brelett
4.MELK SOM DRIKK
(1 glass = 1,5 dl)
Helmelk, søt, sur
Lettmelk, søt, sur
Skummet melk, søt, sur
Drikker
sjelden/
ikke
1/2 1 2 3 4 5
1
2
3
4
5
Mellomgrovt brød
(lys helkorn, lys kneipp, lys hj.bakt o.l.)
Sum skiver pr. dag = ___
Antall skiver pr. uke:  ___ x 7 = ___. Tallet brukes i spørsmål 5.
Antall glass pr. dag
A
B
C
D
E
F
G
H
I
J
K
L
M
A2
B2
C2
D2
E2
F2
G2
H2
I2
J2
K2
L2
M2
10 119 12+
3.OM DU BRUKER
FETT PÅ BRØD, HVOR
MYE BRUKER DU?
6 7 8+
3
Soft-, soyamargarin (pakke, beger)
Solsikke
Oliven
Soft light
Annen margarin
Vita
Olivero
Omega
Vita lett
Lettmelk, ekstra lett
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5.PÅLEGGSSORTER
Bruk sum skiver pr. uke fra spørsmål 1.
Brun ost, prim
Hvit ost, helfet, 27% fett (Jarlsberg,
Norvegia o.l., smøreost; eske, tube)
Hvit ost, halvfet, 16% fett (Jarlsberg,
Norvegia o.l. smøreost; eske, tube)
Ost med mer enn 27% fett
(kremoster, Normanna, Ridderost)
Leverpostei, vanlig
Servelat, vanlig
Lett servelat, kalverull,
kokt skinke, okserull o.l.
Salt pølse, spekepølse
(fårepølse, salami o.l.)
Kaviar
Makrell i tomat, røkt makrell
Sardiner, sursild, ansjos o.l.
Laks, ørret
Reker, krabbe
Syltetøy, marmelade, frysetøy
Honning, sirup,
sjokolade-, nøttepålegg
Grønnsaker som pålegg
(agurk, tomat o.l.)
Frukt som pålegg (banan, eple o.l.)
Salater med majones
6. EGG
(kokt, stekt, eggerøre, omelett)
Antall pr. uke
0
Mindre
enn 1 1 2 3-4 5-6 7 8+
1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-350
Leverpostei, mager
Majones på smørbrød
Til antall skiver pr. uke
1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-350
1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-350
1/2 1 2-3 4-5 6-7 8-14 15-21 22-2829-350
1/2 1 2-3 4-5 6-7 8-14 15-21 22-28 29-350
36+
36+
36+
36+
36+
4
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7. FROKOSTGRYN, GRØT OG YOGHURT
Svar enten pr. måned eller pr. uke. <1 betyr sjeldnere enn 1 gang.
Havregryn,kornblandinger
(4-korn, usøtet müsli o.l.)
Gang pr. måned                        Gang pr. uke                 Mengde pr. gang
Cornflakes, puffet ris,
havrenøtter o.l.
Havregrøt
Sukker til frokostgryn, grøt
Yoghurt, naturell, frukt
Go'morgen yoghurt,
inkl. müsli
0 <1 1 2 3 1 2-3 4-5 6-7 8+
8.KAFFE OG TE
(1 kopp kaffe = 1,2 dl   1 kopp te = 2 dl)
Antall kopper pr. dag
Drikker
ikke/ikke
daglig 1/2 1 2 3-4 5-6 7-8 9-10
Kaffe, kokt
Te
Antall teskjeer eller biter pr. kopp
Sukker til kaffe
Kunstig søtstoff til kaffe eller te
0 1/2 1 2 3 4+
Melk søt, sur på gryn,
grøt og dessert
Lettyoghurt
Kaffe, traktet, filter
Kaffe, pulver (instant)
Kaffe, koffeinfri
Nypete, urtete
(dl)
(dl)
(dl)
(ts)
(beger)
(dl)
1 11/2 2
1 11/2 2
1-2 3-4 5-6
21 3-4
1/2 1 11/2
1/2 1 11/2
1/2 1 11/2
3/4 1 2
(beger)
(beger)
3+
3+
7
5+
2+
2+
2+
3+
11+
Fløte til kaffe
5
Sukker til te
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9. ANDRE DRIKKER
Svar enten pr. måned eller pr. uke.  < 1 betyr sjeldnere enn 1 gang. Merk at
porsjonsenhetene er forskjellige. 1/3 liter tilsvarer en halvflaske øl og 2/3 liter
tilsvarer en helflaske.
Vann
Gang pr. måned                  Gang pr. uke                   Mengde pr. gang
Appelsinjuice
Annen juice, most, nektar
Saft, solbærsirup m.
sukker
Saft, kunstig søtet
Brus, Cola, Solo o.l.
med sukker
Brus, Cola, Solo o.l.
kunstig søtet
Farris, Selters, Soda o.l.
Alkoholfritt øl, vørterøl,
lettøl
Pilsnerøl
Vin
Brennevin, likør
(glass)
(glass)
(glass)
(glass)
10. MIDDAGSRETTER
Vi spør både om middagsmåltidene og det du spiser til andre måltider. Tell til slutt
sammen antall retter du har merket av for å se om summen virker sannsynlig.
En "dl" tilsvarer omtrent mengden i en suppeøse. Med "ss" menes en spiseskje.
Gang pr. måned                                      Mengde pr. gang
0 <1 1 2 3 4 5-6 7-8 9+
Kjøttpølse, medisterpølse
Hamburger, karbonader o.l.
Grill- og wienerpølse
Hamburger-, pølsebrød,
lomper
Kjøttdeigretter (saus eller gryte
med kjøttdeig, lasagne o.l.)
Taco (med kjøtt og salat)
(kjøttpølse)
(stk)
(pølse)
(stk)
(stk)
(stk)
0 <1 1 2 3 1 2-3 4-5 6-7 8+
Pastaretter
Kjøttkaker, medisterkaker,
kjøttpudding
(glass)
(liter)
(liter)
(liter)
(liter)
(liter)
(glass)
(1 dram
   =4cl)
(dl)
(dl)
1 2 3 4 5
1 2 3 4 5
1/2 2/3 1 11/2 2+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1/4 1/3 1/2 2/3 1 11/2+
1/4 1/3 1/2 2/3 1 11/2+
1/4 1/3 1/2 2/3 1 11/2+
1/4 1/3 1/2 2/3 1 11/2+
1/4 1/3 1/2 2/3 1 11/2+
1/2 1 2 3 4 5+
1/2 1 2 3 4 5+
1/2 1 2 3 4 5+
1/2 1 2 3 4 5+
1/2 1 2 3 4 5+
6+
6+
6
1 2 3 4 5+
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Gang pr. måned                                        Mengde pr. gang
0 <1 1 2 3 4 5-6 7-8 9+
1/8 1/41/2 3/4 1+
Koteletter (lam, okse, svin)
(dl)
(stk)
Stek (lam, okse, svin)
Stek (elg, hjort, reinsdyr o.l.)
Gryterett med helt kjøtt,
frikassè, fårikål o.l.
Lapskaus, suppelapskaus,
betasuppe
Bacon, stekt flesk
Kylling, høne
Leverretter
Fiskekaker, fiskepudding,
fiskeboller
Fiskepinner
Torsk, sei, hyse (kokt)
Torsk, sei, hyse (stekt, panert)
Sild (fersk, speket, røkt)
Makrell (fersk, røkt)
Laks, ørret (sjø, oppdrett)
Fiskegryte, -grateng, suppe
med fisk
Reker, krabbe
Risgrøt, annen melkegrøt
Pannekaker
Suppe (tomat, blomkål,
ertesuppe o.l.)
Vegetarrett, vegetarpizza,
grønnsaksgrateng, -pai
Brun/hvit saus
Bearnaisesaus o.l.
Majones, remulade
Ketchup
Smeltet margarin, smør
til fisk
Pizza (500-600 g)
Biff (alle typer kjøtt)
(stk)
(skive)
(skive)
(skive)
(kake)
(stk)
(stk)
(filet)
(filet)
(dl)
(dl, renset)
(dl)
(dl)
(dl)
(ss)
(ss)
(ss)
(ss)
1/2 1 11/2 2 21/2+
1/2 1 11/2 2 21/2+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
(pizza)
(stk)
(stk)
(skive)
(skive)
(dl)
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1/4 1/3 1/2 3/4 1+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1 2 3 4 5+
1/2 1 11/2 2 3+
1-2 3-4 5-6 7-9 10+
1 2 3 4 5+
1 2 3 4 5+
(bit/dl)
1/2 1 11/2 2 21/2+
(stk)
0 <1 1 2 3 4 5-6 7-8 9+
0 <1 1 2 3 4 5-6 7-8 9+
0 <1 1 2 3 4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
1-2 3-4 5-6 7-8 9+
7
1-2 3-4 5-6 7-8 9+
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11. POTETER, RIS, SPAGHETTI, GRØNNSAKER
Poteter, kokte
Gang pr. måned                  Gang pr. uke                   Mengde pr. gang
(stk)
Pommes frites, stekte
poteter
Potetmos, -stuing,
gratinerte poteter
Ris
Spaghetti, makaroni,
pasta
Gulrot
Hodekål
Brokkoli
Erter, frosne grønnsak-
blandinger
Salatblandinger
Dressing
Rømme
(dl)
(dl)
0 <1 1 2 3 1 2-3 4-5 6-7 8+
Kålrot
Blomkål
Løk
Spinat, andre bladgrønns.
Tomatbønner, bønner/linser
Rosenkål
Grønnkål
Sopp
Tomat
(dl)
(dl)
(dl)
(dl)
(dl)
41 2 3
41 2 3
41 2 3
7-81-2 3-4 5-6
7-81-2 3-4 5-6
1/2 1 11/2 2
(stk)
(stk)
(stk)
(stk)
(skalk)
(skive)
(bukett)
(bukett)
41 2 3
41 2 3
7-81-2 3-4 5-6
7-81-2 3-4 5-6
1/2 1 11/2 2
1/2 1 2 3
1/2 1 2 3
(ss)
(ss)
(dl)
(ss)
(dl)
41 2 3
41 2 3
41 2 3
7-81-2 3-4 5-6
41 2 3
41 2 3
41 2 3
Svar enten pr. måned eller pr. uke.  < 1 betyr sjeldnere enn 1 gang.
Disse spørsmålene dreier seg først og fremst om tilbehør til middagsretter, men
spiser du for eksempel en rå gulrot eller salat til lunsj, skal det tas med her.
Hvor mange ganger om dagen spiser du vanligvis
grønnsaker utenom grønnsakene du spiser til middag?
5+
5+
5+
9+
9+
3+
5+
5+
9+
9+
7-85-63-41-2 9+
5+
5+
5+
9+
3+
5+
5+
5+
4+
4+
8
41 2 3 5+0
Avocado
Paprika
(stk)
(strimmel)
1/4 1/2 3/4 1 11/4+
41 2 3 5+
Mais (ss)
7-81-2 3-4 5-6 9+
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12. TYPE FETT TIL MATLAGING
Smør (meierismør)
Bremykt
Melange, Per
Olivenolje
Soyaolje
A3
B3
C3
D3
E3
F3
G3
13. FRUKT
Svar enten pr. måned eller pr. uke. < 1 betyr sjeldnere enn 1 gang.
1/2 1 2 3+
Eple
Gang pr. måned               Gang pr. uke                        Mengde pr. gang
(stk)
Appelsin, mandarin,
grapefrukt
Banan
Druer
Jordbær, bringebær
(friske, frosne)
(stk)
(stk)
(klase)
0 <1 1 2 3 1 2-3 4-5 6-7 8+
Eksotisk frukt (kiwi, mango)
Annen frukt (fersken,
pære m.v.)
Hvor mange frukter spiser du vanligvis pr. dag?
(stk)
(stk)
(dl)
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
1/2 1 2 3+
Blåbær (dl)
1/2 1 2 3+
Andre oljer
1/2 1 2 3+
A4
B4
C4
D4
E4
F4
Maisolje
Solsikkeolje
Valnøttolje
1 2 3 4 50 6
9
Soft-, soyamargarin (pakke, beger)
Solsikke
Annen margarin
Oliven
Smør/margarin Oljer
7 8 9+
Multer (dl)
1/2 1 2 3+
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14. DESSERT, KAKER, GODTERI
 Svar enten pr. måned eller pr. uke. < 1 betyr sjeldnere enn 1 gang.
1/2 1 2 3+
Gang pr. måned                Gang pr. uke                     Mengde pr. gang
Hermetisk frukt, fruktgrøt
Puddinger (sjokolade,
karamell o.l.)
Is (1 dl=1 pinne=1
kremmerhus)
Boller, julekake, kringle
Skolebrød, skillingsbolle
Wienerbrød, -kringle o.l.
Smultring, formkake
Vafler
Sjokoladekake, bløtkake,
annen fylt kake
Søt kjeks, kakekjeks
(Cookies, Bixit, Hob Nobs)
Sjokolade (60 g)
Drops, lakris, seigmenn o.l.
Potetgull (1 pose 100g=7 dl)
Annen snacks (skruer, crisp,
saltstenger, lettsnacks o.l.)
Peanøtter, andre nøtter
(1 pose 100g = 4 never)
0 <1 1 2 3 1 2-3 4-5 6-7 8+
Smågodt (1 hg = 100g)
1/2 1 2 3+
(stk)
(stk)
(stk)
(stk)
(stk)
(stk)
(dl)
(dl)
(dl)
(dl)
(dl)
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
(plate)
7+1-2 3-4 5-6
7+1-2 3-4 5-6
7+1-2 3-4 5-6
4+1 2 3
(neve)
1/2 1 2 3+
1/2 1 2 3+
(plate)
(stk)
(hg)
7+1-2 3-4 5-6
4+1 2 3
1/2 3/4 1 11/2+
10
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15. KOSTTILSKUDD (bs = barneskje, ts = teskje)
1 ts 1 bs 1 ss
Gang pr. uke                     Mengde pr. gang
Tran
Trankapsler
Fiskeoljekapsler
Multipreparater
Sanasol
Biovit
Vitaplex
Kostpluss
Vitamineral
Annet
Jernpreparater
Ferro C
Hemofer
Annet
B-vitaminer
C-vitamin
D-vitamin
E-vitamin
Folat (folsyre)
Kalktabletter
Fluortabletter
Hele
året
Bare vinter-
halvåret
Annet
1 2+
7+1-2 3-4 5-6
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
bs
bs
tablett
tablett
tablett
tablett
0 <1 1 2-3 4-5 6-7
0 <1 1 2-3 4-5 6-7 4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
4+1 2 3
0 <1 1 2-3 4-5 6-7
4+1 2 3
0 <1 1 2-3 4-5 6-7
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
tablett
0 <1 1 2-3 4-5 6-7
11
kapsler
kapsler
Hvis annet, hvilket?.....................................................
Duroferon
Duretter
4+1 2 3
tablett
Hvis annet, hvilket?.....................................................
Hvis annet, hvilket?......................................................
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16. NÅR SPISER DU PÅ HVERDAGER?
HOVEDMÅLTIDER som frokost, formiddagsmat, middag, kvelds.
Omtrent klokken
MELLOMMÅLTIDER som kaffe, frukt, godteri, snacks m.v.
Omtrent klokken
A5 B5 C5 D5 E5 F5 G5 H5 I5 J5 K5 L5 M5 N5 O5 P5 Q5 R5 S5 T5 U5 V5 W5
A6 B6 C6 D6 E6 F6 G6 H6 I6 J6 K6 L6 M6 N6 O6 P6 Q6 R6 S6 T6 U6 V6 W6
17. MENER DU SVARENE I SPØRRESKJEMAET
       GIR ET BRUKBART BILDE AV KOSTHOLDET
Er det matvarer/produkter du regelmessig bruker, og som ikke er nevnt i skjemaet?
......................................................................................................................
......................................................................................................................
Ja Nei
18. ER DU FORNØYD MED KROPPSVEKTEN DIN SLIK DEN ER NÅ?
Ja
Nei, jeg ønsker å slanke meg
Nei, jeg ønsker å legge på meg
Vennligst se etter at du har svart på alle spørsmål.
Takk for innsatsen!
8 10 12 14 16 18 20 22 24 2 46
8 10 12 14 16 18 20 22 24 2 46
12
19. KJØNN
Mann Kvinne
24756
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